Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person FMO1:FAD N-oxidises TAM

Class:IdReaction:217255
_displayNameFMO1:FAD N-oxidises TAM
_doReleaseTRUE
_timestamp2023-08-22 22:22:21
authored[InstanceEdit:350358] Jassal, Bijay, 2008-05-19
catalystActivity[CatalystActivity:217265] N,N-dimethylaniline monooxygenase activity of FMO1:FAD [endoplasmic reticulum membrane]
compartment[Compartment:17960] smooth endoplasmic reticulum
created[InstanceEdit:217275] Jassal, B, 2008-03-26 09:20:04
edited[InstanceEdit:350358] Jassal, Bijay, 2008-05-19
input[SimpleEntity:113534] O2 [endoplasmic reticulum lumen]
[SimpleEntity:113601] NADPH [endoplasmic reticulum lumen]
[SimpleEntity:156540] H+ [endoplasmic reticulum lumen]
[ChemicalDrug:9838650] TAM [endoplasmic reticulum lumen]
literatureReference[LiteratureReference:217273] Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin
modified[InstanceEdit:217278] Jassal, B, 2008-03-26 09:21:20
[InstanceEdit:350661] Jassal, Bijay, 2008-05-20
[InstanceEdit:351778] Jassal, Bijay, 2008-05-28
[InstanceEdit:352324] Jassal, B, 2008-06-02 12:56:30
[InstanceEdit:389952] Jassal, Bijay, 2009-01-21
[InstanceEdit:5603083] Jassal, Bijay, 2014-06-27
[InstanceEdit:9830342] Matthews, Lisa, 2023-03-08
[InstanceEdit:9838651] D'Eustachio, Peter, 2023-06-23
[InstanceEdit:9842210] Matthews, Lisa, 2023-08-22
nameFMO1:FAD N-oxidises TAM
FMO1 N-oxidizes the anti-cancer drug tamoxifen
output[SimpleEntity:217269] TAMO [endoplasmic reticulum lumen]
[SimpleEntity:113519] H2O [endoplasmic reticulum lumen]
[SimpleEntity:113564] NADP+ [endoplasmic reticulum lumen]
previousReviewStatus[ReviewStatus:9821384] two stars
releaseDate2008-06-30
reviewed[InstanceEdit:351775] D'Eustachio, P, 2008-05-28 08:30:54
[InstanceEdit:9842118] D'Eustachio, Peter, 2023-08-18
reviewStatus[ReviewStatus:9821382] five stars
revised[InstanceEdit:5602271] Jassal, Bijay, 2014-06-23
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:361950] R-HSA-217255.3
structureModified[InstanceEdit:9838651] D'Eustachio, Peter, 2023-06-23
summation[Summation:217260] Tamoxifen (TAM) is an antiestrogen and currently used extens...
(hasEvent)[Pathway:217271] FMO oxidises nucleophiles [Homo sapiens]
(updatedInstance)[_UpdateTracker:9791578] Update Tracker - [Reaction:217255] FMO1:FAD N-oxidises TAM - v28:[addInput]
[_UpdateTracker:9842316] Update Tracker - [Reaction:217255] FMO1:FAD N-oxidises TAM - v86:[add_removeInput]
[Change default viewing format]
No pathways have been reviewed or authored by FMO1:FAD N-oxidises TAM (217255)